支气管透视干预可以减少严重症状的中央恶性气道阻塞患者的喘息
Malin Svensson1, Andreas Palm2, Nilla Westöö3
1Department of Surgical Sciences (M.S.), Uppsala University, Uppsala, Sweden; Ear, Nose, and Throat Clinic (M.S., N.W.), Uppsala University Hospital, Uppsala, Sweden.
Journal of pain and symptom management
|March 27, 2025
概括
内镜干预显著改善恶性中央气道阻塞 (MCAO) 患者的症状和生活质量. 性能状况较差的患者从这些程序中获得了更大的好处.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 干预性内镜检查是干预性的内镜检查.
背景情况:
- 恶性中央气道阻塞 (MCAO) 是一个严重的,危及生命的临床挑战.
- 有效的管理策略对于改善患者的治疗结果至关重要.
研究的目的:
- 评估内镜干预对MCAO患者呼吸障碍,生活质量 (QoL) 和生理参数的影响.
- 确定可能从这些程序中获得更大的好处的患者子组.
主要方法:
- 一个单一中心前性队列研究,涉及44名MCAO患者接受支气管镜干预.
- 术前和术后的评估包括呼吸速率,FEV1,氧和和验证的问卷 (NRS呼吸障碍,CDS,EORTC QLQ-C30,EORTC QLQ-LC13,ECOG-PS).
主要成果:
- 支气管镜干预导致呼吸率,癌症呼吸障碍量 (CDS) 评分和NRS呼吸障碍评分在术后显著降低.
- 在1秒内强迫呼气体积 (FEV1) 显示显著增加.
- 呼吸障碍得分和全球健康量表 (GHS) 的改善在1个月的随访后持续,特别是在ECOG性能状态 (PS) ≥2.2的患者中.
结论:
- 支气管镜干预为大多数MCAO患者提供了巨大的好处,缓解症状并增强QoL.
- 患有较差ECOGPS (≥2) 的患者在这些内镜手术后可能会经历更明显的症状缓解和功能改善.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
Pneumothorax-II
1.7K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.7K
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
958
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
958
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40


